AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, today announced presentations at the ...

Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today announced three presentations that underscore ...

Eyes have long been called a window to the world — but new research suggests they may also reveal the state of a person’s ...

This species is the first and only one to have gone extinct twice, highlighting that de-extinction isn't so simple.

The Creative Biogene division IntegrateRNA launched a novel platform that enables post-translational protein modification through the use of non-canonical amino acids and engineered transfer RNA. The ...

Velsera and Complete Genomics are expanding their ability to serve clinical labs with an end-to-end solution from sample to ...